What is the proper preparation and usage of Condy's solution (potassium permanganate) for treating weeping, exudative skin conditions such as infected eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Condy's Solution (Potassium Permanganate) for Dermatology

Prepare potassium permanganate solution at a dilution of 1:10,000 (0.01%) for treating weeping, exudative, and infected skin conditions such as eczema, fissures, and periungual infections. 1

Preparation Method

The standard therapeutic concentration is 1:10,000 (0.01%):

  • Dissolve one 400mg tablet in 4 liters of water 2
  • The solution should appear pale pink/light purple in color
  • Visual assessment is more reliable than formulaic calculations - the solution should be pale pink, not dark purple 3

Critical safety note: Some clinical practice uses more dilute concentrations (1:80,000 or 0.00125%), but guideline-recommended concentration remains 1:10,000 3. The key is achieving a pale pink color to avoid chemical burns.

Clinical Indications

Primary Uses:

  • Weeping/exudative eczema and infected dermatoses 1, 4
  • Skin fissures - accelerates wound closure 1
  • Periungual infections and nail problems 1
  • Impetiginized dermatoses (secondary bacterial infection) 5

Application Methods:

For localized lesions:

  • Apply as compresses or soaks to affected areas 6
  • Duration: typically 10-30 minutes

For widespread involvement:

  • Add to bath water at 1:10,000 dilution 1, 4
  • Daily baths during acute exacerbations 4

For fissures specifically:

  • Use as antiseptic baths at 1:10,000 concentration 1
  • Alternative: combine with propylene glycol 50% under occlusion 1

Mechanism and Benefits

Potassium permanganate functions as:

  • Antiseptic with oxidizing properties 6
  • Astringent - dries weeping lesions 6, 2
  • Antibacterial and antibiofilm activity against Staphylococcus aureus, which colonizes up to 94-100% of atopic dermatitis patients 4, 7

Recent evidence shows 0.05% concentration completely kills S. aureus isolates, while 0.01% inhibits biofilm formation 7. This is particularly relevant since biofilm-producing staphylococci worsen AD severity 4, 7.

Important Caveats and Safety

Contraindications and Incompatibilities:

  • Never use with soap or anionic detergents 8
  • Avoid mixing with iodine or peroxides (hydrogen peroxide, povidone-iodine) 8
  • Do not use with organic materials that can react with the oxidizing agent 8
  • For external use only - keep away from children due to ingestion risk 8, 6

Adverse Effects:

  • Staining: Discolors skin (brown/purple), clothing, and bathroom fixtures 6
  • Chemical burns: Can occur with excessive concentration 6
  • Systemic toxicity: Rare but serious if ingested 6

Practical Tips:

  • Use gloves during preparation to avoid staining hands
  • Protect bathroom surfaces or use disposable containers
  • Reassess after 2 weeks - if no improvement, escalate treatment 1

Integration with Other Treatments

Potassium permanganate works as an adjunctive antiseptic treatment, not monotherapy:

  • Combine with appropriate topical corticosteroids for inflammatory component 1, 9
  • Add systemic antibiotics (flucloxacillin, erythromycin) for overt secondary infection 9
  • Follow with emollients after drying to prevent excessive xerosis 1
  • For severe cases with toxigenic S. aureus, consider oral cefalexin with topical chlorhexidine and mupirocin to nares 4

Clinical Context

While newer treatments exist for atopic dermatitis (dupilumab, JAK inhibitors, topical calcineurin inhibitors) 10, 11, 12, potassium permanganate remains valuable for its low cost, reduced allergenic potential, and specific efficacy against weeping, infected lesions 6. It serves a distinct niche for acute exacerbations with secondary infection rather than maintenance therapy.

References

Research

Skin cleansing in children.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2001

Research

Potassium permanganate: a 'desert island drug' in dermatology.

Clinical and experimental dermatology, 2022

Research

European Guideline (EuroGuiDerm) on atopic eczema: Living update.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.